CHMX · As filed with the SEC

NEXT-ChemX balance sheet, by quarter

The statement as NEXT-ChemX presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Condensed Balance Sheets (Unaudited) · USD

USDQ2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
ASSETS
Current Assets:
Cash and Cash Equivalents22,04161262,54735,386
Other Non-Operating Current Assets40,97347,24838,54968,229
Other Non-Operating Current Assets635,041617,003604,368591,070
Total Current Assets698,055664,863705,464694,685
Property, Plant and Equipment4,7055,9517,2858,619
Intangible Assets2,467,2942,504,7402,542,1853,150,114
Total Non-current Assets2,471,9992,510,691—3,158,733
Total Assets3,170,0543,175,5543,254,9343,853,418
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts Payable3,441,2363,329,2573,119,2813,020,703
Nonrelated Party500,000500,000500,000511,980
Related Party127,215139,015107,445104,445
Short-Term Debt845,000845,000845,000845,000
Total Current Liabilities4,913,4514,813,2724,571,7264,482,128
Non-Current Liabilities:
Long-Term Debt2,080,0041,730,0041,585,0041,220,004
Total Non-Current Liabilities2,080,0041,730,0041,585,0041,220,004
Total Liabilities6,993,4556,543,2766,156,7305,702,132
Stockholders’ Equity (Deficit):
Series A Preferred Stock—202020
Series F Preferred Stock—202020
Total Stockholders' Equity28,54728,54728,54728,547
Additional Paid-In Capital5,396,0535,396,0535,396,0535,396,053
Retained Earnings(9,248,001)(8,792,362)(8,326,436)(7,273,354)
Total Stockholders’ Equity (Deficit)(3,823,401)(3,367,722)(2,901,796)(1,848,714)
Total Liabilities and Stockholders’ Equity (Deficit)3,170,0543,175,5543,254,9343,853,418

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.